Jefferies Assumes Pacira Pharmaceuticals (PCRX) at Buy

October 20, 2022 4:29 PM EDT Send to a Friend
Jefferies analyst Glen Santangelo assumes coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login